NHS

RwHealth, Series A, Maven VC, Guinness Asset Management, ICON Corporate Finance, AI, NHS
By  Tammy Lovell 01:30 pm November 1, 2021
London-based artificial intelligence (AI) provider, RwHealth, has announced a raise of €7.2 million ($8.4m) in Series A funding. Maven VC and Guinness Asset Management led the round, along with ICON Corporate Finance. WHAT IT DOES Founded in 2017, RwHealth’s platform combines AI machine learning and data science to give healthcare providers access to data which can aid their decision-making....
ORCHA, COVID-19, health apps, NHS, physiotherapy
By  Tammy Lovell 10:47 am October 20, 2021
Online searches for digital health products in the UK increased by 343% during the first lockdown, according to a new public health study. Research scientists led by Simon Leigh, head of research at the Organisation for the Review of Health and Care Applications (ORCHA) examined web-based internet searches for digital health products before and during the COVID-19 pandemic. The study, published...
Babylon, funding
By  Tammy Lovell 03:53 pm October 12, 2021
Digital health firm Babylon has secured a sustainability-linked investment of up to $200 million (€173M) from the strategic capital investment firm, Albacore Capital Group. Together with already committed PIPE capital of $230 million (€199M) from institutional and strategic investors, Babylon will now have access to around $775 million (€671M) of capital (before fees).  In June Babylon announced...
ORCHA, NHS, digital health apps, weight management, mental health, dementia, Integrated care systems
By  Tammy Lovell 05:01 am October 8, 2021
People across the South-West of England will be given access to digital health libraries, through a partnership between the Organisation for the Review of Care and Health Apps (ORCHA) and seven Integrated Care Systems (ICSs). It follows the success of the Our Dorset programme, which allows health and care staff to recommend apps focused on mental health, dementia, diabetes and cancer support to...
By  Tammy Lovell 11:44 am September 13, 2021
The NHS today announced it is launching the world’s largest trial of a blood test which can detect more than 50 types of cancer before symptoms appear. Research has shown the Galleri test is effective at finding cancers that are typically difficult to identify early, including head and neck, bowel, lung, pancreatic, and throat cancers. It works by finding chemical changes in fragments of genetic...
Cera, Moodbeam, Yext, NHS, doctor finder solution, remote consultations
By  Sara Mageit 08:49 am September 10, 2021
UK GOVERNMENT ANNOUNCES £113M FUNDING TO BRING INNOVATION Ninety-seven of the UK's future science leaders will benefit from a £113 million cash boost to help turn science into new products and services. Announced by science minister Amanda Solloway this week, the boost will support projects such as robotics to help British farmers, new therapies to tackle chronic illnesses and unlocking the...
By  Sara Mageit 10:04 am August 2, 2021
DigitalHealth.London has opened applications to their flagship Accelerator programme for the next generation of digital health companies to bolster health and care. The NHS delivered programme has supported digital companies now being used by the NHS in London, including LIVI, Oxehealth, Patchwork Health, Echo, Sweatcoin, and Health Navigator. Applications open today for six weeks. The deadline...
Medovate, Omneya Medical Co, SAFIRA, NHS, Class II Medical Device
By  Rachel McArthur 02:52 am May 26, 2021
Medovate, a medical device development company in the United Kingdom, has announced its first partnership in the Middle East. The Cambridge-based specialist has teamed up with Kuwait’s Omneya Medical Co. to distribute its SAFIRA (SAFer Injection for Regional Anesthesia) device in the Gulf country. Developed “in collaboration with clinicians from the National Health Service (NHS) in the UK,”...
gammaCore, headache, covid-19, nhs
By  Sophie Porter 11:38 am April 7, 2021
gammaCore, a handheld device used to alleviate cluster headaches, is now availble through NHS England following successful trials. The roll out of the medical device is supported by the Medtech Funding Mandate, which fast-tracks innovations in the NHS. This mandate is part of the NHS Long Term Plan and came into effect on 1 April 2021. WHY IT MATTERS gammaCore works to relieve pain by delivering...
digital innovation, Novartis
By  Sara Mageit 05:57 am March 29, 2021
Pharma giant Novartis Pharmaceuticals UK and UK provider of digital healthcare solutions, Cievert has announced a digital innovation partnership. The collaboration will support patient care in rheumatology and dermatology by capturing patient-reported data. The partnership was created via the Novartis BIOME, a project which encourages impactful collaboration in science tech, with a selection...